Proposal Brief
Icon

Industry

Pharmaceuticals

Icon

Sub Industry

Integrated

Icon

Deal Size

INR 100 - 200 Cr

Icon

Preferred Location

India

Icon

Region

Northern

Icon

Open for Distressed Assets

Yes

Target Requirement

A pharmaceutical client is looking out for acquiring a GMP / MHRA approved/certified Formulation plant having a capacity of approx 200-250 MT per month and an API plant having capacity of producing volume building API’s ( paracetamol, ibuprofen, Metformin) of around 300 – 500 MT per month anywhere in India. The firm has established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliance. The Plants are approved by prestigious US FDA, UK MHRA, Australian TGA and other foreign health authorities. R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development.

Business Operation Information
Business Documents